| MeSH term | MeSH ID | Detail |
|---|---|---|
| Pancreatic Neoplasms | D010190 | 77 associated lipids |
| Parkinson Disease | D010300 | 53 associated lipids |
| Prostatic Neoplasms | D011471 | 126 associated lipids |
| Thrombosis | D013927 | 49 associated lipids |
| Weight Loss | D015431 | 56 associated lipids |
| Leukemia, B-Cell | D015448 | 3 associated lipids |
| Lymphoma, B-Cell | D016393 | 24 associated lipids |
| Lymphoma, T-Cell | D016399 | 11 associated lipids |
| Graves Ophthalmopathy | D049970 | 3 associated lipids |
| Atherosclerosis | D050197 | 85 associated lipids |
15-deoxy-delta-12,14-PGJ2
15-deoxy-delta-12,14-pgj2 is a lipid of Fatty Acyls (FA) class. 15-deoxy-delta-12,14-pgj2 is associated with abnormalities such as Dehydration and Myocardial Ischemia. The involved functions are known as Binding (Molecular Function), Inflammation, Alveolar ventilation function, Stimulus and Process. 15-deoxy-delta-12,14-pgj2 often locates in Cytosol, Myocardial tissue and Heart tissue. The associated genes with 15-deoxy-delta-12,14-PGJ2 are Homologous Gene and G-substrate. The related lipids are 15-deoxyprostaglandin J2 and Lipopolysaccharides.
Cross Reference
Introduction
To understand associated biological information of 15-deoxy-delta-12,14-PGJ2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with 15-deoxy-delta-12,14-PGJ2?
15-deoxy-delta-12,14-PGJ2 is suspected in Dehydration, Myocardial Ischemia and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 15-deoxy-delta-12,14-PGJ2
PubChem Associated disorders and diseases
What pathways are associated with 15-deoxy-delta-12,14-PGJ2
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with 15-deoxy-delta-12,14-PGJ2?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with 15-deoxy-delta-12,14-PGJ2?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with 15-deoxy-delta-12,14-PGJ2?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with 15-deoxy-delta-12,14-PGJ2?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with 15-deoxy-delta-12,14-PGJ2?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with 15-deoxy-delta-12,14-PGJ2
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| He S et al. | Identification, organ expression and ligand-dependent expression levels of peroxisome proliferator activated receptors in grass carp (Ctenopharyngodon idella). | 2012 | Comp. Biochem. Physiol. C Toxicol. Pharmacol. | pmid:22079418 |
| Collin M et al. | Role of peroxisome proliferator-activated receptor-gamma in the protection afforded by 15-deoxydelta12,14 prostaglandin J2 against the multiple organ failure caused by endotoxin. | 2004 | Crit. Care Med. | pmid:15090969 |
| Cuzzocrea S | Peroxisome proliferator-activated receptors and acute lung injury. | 2006 | Curr Opin Pharmacol | pmid:16580256 |
| Yasugi E et al. | Peroxisome proliferator-activated receptor gamma ligands stimulate myeloid differentiation and lipogenensis in human leukemia NB4 cells. | 2006 | Dev. Growth Differ. | pmid:16573735 |
| Souza SC et al. | BRL 49653 blocks the lipolytic actions of tumor necrosis factor-alpha: a potential new insulin-sensitizing mechanism for thiazolidinediones. | 1998 | Diabetes | pmid:9568706 |
| Maggi LB et al. | Anti-inflammatory actions of 15-deoxy-delta 12,14-prostaglandin J2 and troglitazone: evidence for heat shock-dependent and -independent inhibition of cytokine-induced inducible nitric oxide synthase expression. | 2000 | Diabetes | pmid:10868955 |
| Xie Y et al. | Differentiation-dependent regulation of the cyclooxygenase cascade during adipogenesis suggests a complex role for prostaglandins. | 2006 | Diabetes Obes Metab | pmid:16367886 |
| Artwohl M et al. | Thiazolidinediones inhibit proliferation of microvascular and macrovascular cells by a PPARgamma-independent mechanism. | 2005 | Diabetologia | pmid:15729575 |
| Bruck R et al. | Additive inhibitory effect of experimentally induced hepatic cirrhosis by agonists of peroxisome proliferator activator receptor gamma and retinoic acid receptor. | 2009 | Dig. Dis. Sci. | pmid:18594976 |
| Kim WJ et al. | Anti-inflammatory lipid mediator 15d-PGJ2 inhibits translation through inactivation of eIF4A. | 2007 | EMBO J. | pmid:18034160 |
| Suzuki T et al. | Peroxisome proliferator-activated receptor gamma in human breast carcinoma: a modulator of estrogenic actions. | 2006 | Endocr. Relat. Cancer | pmid:16601291 |
| Schell C et al. | 15-Deoxy-delta 12-14-prostaglandin-J2 induces hypertrophy and loss of contractility in human testicular peritubular cells: implications for human male fertility. | 2010 | Endocrinology | pmid:20133451 |
| Tomlinson JW et al. | Regulation of expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue: tissue-specific induction by cytokines. | 2001 | Endocrinology | pmid:11316764 |
| Poncin S et al. | Oxidative stress in the thyroid gland: from harmlessness to hazard depending on the iodine content. | 2008 | Endocrinology | pmid:17884933 |
| Pirianov G et al. | The cyclopentenone 15-deoxy-delta 12,14-prostaglandin J(2) delays lipopolysaccharide-induced preterm delivery and reduces mortality in the newborn mouse. | 2009 | Endocrinology | pmid:18845626 |
| Ding Q et al. | Identification of macrophage inhibitory cytokine-1 in adipose tissue and its secretion as an adipokine by human adipocytes. | 2009 | Endocrinology | pmid:19074584 |
| GarcÃa-Bueno B et al. | Stress mediators regulate brain prostaglandin synthesis and peroxisome proliferator-activated receptor-gamma activation after stress in rats. | 2008 | Endocrinology | pmid:18079203 |
| Person EC et al. | Albumin regulates induction of peroxisome proliferator-activated receptor-gamma (PPARgamma) by 15-deoxy-delta(12-14)-prostaglandin J(2) in vitro and may be an important regulator of PPARgamma function in vivo. | 2001 | Endocrinology | pmid:11159824 |
| Landrier JF et al. | Adiponectin expression is induced by vitamin E via a peroxisome proliferator-activated receptor gamma-dependent mechanism. | 2009 | Endocrinology | pmid:19833717 |
| Lecka-Czernik B et al. | Divergent effects of selective peroxisome proliferator-activated receptor-gamma 2 ligands on adipocyte versus osteoblast differentiation. | 2002 | Endocrinology | pmid:12021203 |
| Fang M et al. | Activation of Human Peroxisome Proliferator-Activated Nuclear Receptors (PPARγ1) by Semi-Volatile Compounds (SVOCs) and Chemical Mixtures in Indoor Dust. | 2015 | Environ. Sci. Technol. | pmid:26172262 |
| Quinteiro MS et al. | The indirect antinociceptive mechanism of 15d-PGJ2 on rheumatoid arthritis-induced TMJ inflammatory pain in rats. | 2012 | Eur J Pain | pmid:22354681 |
| Dubourdeau M et al. | Opposite roles of STAT and PPARgamma in the induction of p21WAF1 expression by IL-13 in human peripheral blood monocytes. | 2008 | Eur. Cytokine Netw. | pmid:19103521 |
| Liu X et al. | 15-Deoxy-Δ(12,14)-prostaglandin J(2) attenuates the biological activities of monocyte/macrophage cell lines. | 2012 | Eur. J. Cell Biol. | pmid:22560326 |
| Pustovrh MC et al. | MMP/ TIMP balance is modulated in vitro by 15dPGJ(2) in fetuses and placentas from diabetic rats. | 2009 | Eur. J. Clin. Invest. | pmid:19811527 |
| Harris SG and Phipps RP | The nuclear receptor PPAR gamma is expressed by mouse T lymphocytes and PPAR gamma agonists induce apoptosis. | 2001 | Eur. J. Immunol. | pmid:11298334 |
| Berry A et al. | IL-13 induces expression of CD36 in human monocytes through PPARgamma activation. | 2007 | Eur. J. Immunol. | pmid:17458857 |
| Faveeuw C et al. | Prostaglandin D2 inhibits the production of interleukin-12 in murine dendritic cells through multiple signaling pathways. | 2003 | Eur. J. Immunol. | pmid:12672054 |
| Comabella M et al. | Plasma levels of 15d-PGJ are not altered in multiple sclerosis. | 2009 | Eur. J. Neurol. | pmid:19538219 |
| Bernardo A et al. | Role of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma) and its natural ligand 15-deoxy-Delta12, 14-prostaglandin J2 in the regulation of microglial functions. | 2000 | Eur. J. Neurosci. | pmid:10947800 |
| Aoun P et al. | Neuroprotective effects of PPARgamma agonists against oxidative insults in HT-22 cells. | 2003 | Eur. J. Pharmacol. | pmid:12860474 |
| Sugimoto H et al. | CRTH2-specific binding characteristics of [3H]ramatroban and its effects on PGD2-, 15-deoxy-Delta12, 14-PGJ2- and indomethacin-induced agonist responses. | 2005 | Eur. J. Pharmacol. | pmid:16256979 |
| Tang FT et al. | Tanshinone IIA attenuates atherosclerosis in ApoE(-/-) mice through down-regulation of scavenger receptor expression. | 2011 | Eur. J. Pharmacol. | pmid:20854809 |
| Tanaka T et al. | Therapeutic potential of thiazolidinediones in activation of peroxisome proliferator-activated receptor gamma for monocyte recruitment and endothelial regeneration. | 2005 | Eur. J. Pharmacol. | pmid:15680279 |
| Ou YC et al. | Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT. | 2007 | Eur. J. Pharmacol. | pmid:17341418 |
| Inoue K et al. | Effect of 15-deoxy-delta 12,14-prostaglandin J2 on acute lung injury induced by lipopolysaccharide in mice. | 2003 | Eur. J. Pharmacol. | pmid:14642794 |
| Collin M and Thiemermann C | The PPAR-gamma ligand 15-deoxy(delta12,14) prostaglandin J2 reduces the liver injury in endotoxic shock. | 2003 | Eur. J. Pharmacol. | pmid:12969773 |
| Ferreira-Silva V et al. | Effects of 15-deoxy-Delta12, 14 prostaglandin J2 and ciglitazone on human cancer cell cycle progression and death: the role of PPARgamma. | 2008 | Eur. J. Pharmacol. | pmid:18054911 |
| Belvisi MG et al. | Peroxisome proliferator-activated receptor gamma agonists as therapy for chronic airway inflammation. | 2006 | Eur. J. Pharmacol. | pmid:16458290 |
| Kitamura Y et al. | Effects of 15-deoxy-delta(12,14) prostaglandin J(2) and interleukin-4 in Toll-like receptor-4-mutant glial cells. | 2001 | Eur. J. Pharmacol. | pmid:11164379 |
| Neri T et al. | Role of NF-kappaB and PPAR-gamma in lung inflammation induced by monocyte-derived microparticles. | 2011 | Eur. Respir. J. | pmid:21148223 |
| Genovese T et al. | Effect of rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2 on bleomycin-induced lung injury. | 2005 | Eur. Respir. J. | pmid:15684285 |
| Tsao WC et al. | Proteasome inhibitors induce peroxisome proliferator-activated receptor transactivation through RXR accumulation and a protein kinase C-dependent pathway. | 2005 | Exp. Cell Res. | pmid:15707588 |
| Syed MA et al. | Expression of TREM-1 is inhibited by PGD2 and PGJ2 in macrophages. | 2010 | Exp. Cell Res. | pmid:20797396 |
| Hossain MS et al. | Stable expression of lipocalin-type prostaglandin D synthase in cultured preadipocytes impairs adipogenesis program independently of endogenous prostanoids. | 2012 | Exp. Cell Res. | pmid:22100987 |
| Rajasingh J and Bright JJ | 15-Deoxy-delta12,14-prostaglandin J2 regulates leukemia inhibitory factor signaling through JAK-STAT pathway in mouse embryonic stem cells. | 2006 | Exp. Cell Res. | pmid:16737695 |
| Yagami T et al. | Novel binding sites of 15-deoxy-Delta12,14-prostaglandin J2 in plasma membranes from primary rat cortical neurons. | 2003 | Exp. Cell Res. | pmid:14597421 |
| Park KS et al. | Neuronal differentiation of embryonic midbrain cells by upregulation of peroxisome proliferator-activated receptor-gamma via the JNK-dependent pathway. | 2004 | Exp. Cell Res. | pmid:15212945 |
| Kondoh K et al. | Inhibition of estrogen receptor beta-mediated human telomerase reverse transcriptase gene transcription via the suppression of mitogen-activated protein kinase signaling plays an important role in 15-deoxy-Delta(12,14)-prostaglandin J(2)-induced apoptosis in cancer cells. | 2007 | Exp. Cell Res. | pmid:17706193 |
| Richard CL et al. | 15-Deoxy-delta(12,14)-prostaglandin J(2) down-regulates CXCR4 on carcinoma cells through PPARgamma- and NFkappaB-mediated pathways. | 2007 | Exp. Cell Res. | pmid:17707368 |